← Eichor
Study identifier: NCT07298343 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Evaluating the Efficacy and Tolerability of ZED1227 in Subjects With Non-responsive Celiac Disease

Condition: Celiac Disease  ·  Sponsor: Dr. Falk Pharma GmbH

PhasePhase 2
Planned participants356
Who can joinAll sexes, 18 Years to 80 Years
Healthy volunteersNo

About this study

A study to discover if ZED1227 can improve continued celiac disease symptoms despite a gluten-free diet

This description comes directly from the study's public registry record.

Talk to the study team

Contact details are listed per location below or on the registry record.

Always discuss trial participation with your own doctor first.

Locations (1)

University Medical Center MainzMainz, GermanyRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07298343